Systemic treatments for inflammatory breast cancer

Charles H. Yang, Massimo Cristofanilli*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

14 Scopus citations


Inflammatory breast cancer is rare but represents the most aggressive and lethal form of locally advanced breast cancer. The management of inflammatory breast cancer has evolved substantially over the last 40 years; current multimodality therapy regimens combine chemotherapy, surgery, and radiation. While identification of the optimal combination of these traditional therapies remains a goal, novel targeted therapies that have recently become available promise improved responses and survival. In this review, we discuss some recent developments in the use of systemic therapies for inflammatory breast cancer.

Original languageEnglish (US)
Pages (from-to)55-65
Number of pages11
JournalBreast Disease
StatePublished - 2005


  • Inflammatory breast cancer
  • Systemic therapy
  • Targeted therapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Systemic treatments for inflammatory breast cancer'. Together they form a unique fingerprint.

Cite this